Follow the people · Insider

LT

Lynn A. Tetrault

Insider · Director · ALMS

Lynn A. Tetrault files insider transactions with the SEC as a director of Alumis (ALMS). We hold 3 disclosed purchases and sales filed since 15 July 2015, 3 of them in the last 90 days.

  • Files forALMS
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure2 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 30 July 202530 June 2026Director · Alumis (ALMS)3 Form 4 lines · source: SEC Form 4
  • Filed 9 December 202024 June 2026Director · Rhythm Pharmaceuticals (RYTM)37 Form 4 lines · source: SEC Form 4
  • Filed 15 July 201515 June 2026Director · Neogenomics (NEO)56 Form 4 lines · source: SEC Form 4
  • Filed 18 December 202321 May 2025Director · Acelyrin (SLRN)4 Form 4 lines · source: SEC Form 4

Everything they disclosed

100 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.